Lymphocytosis
Information
- Disease name
- Lymphocytosis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00001533 | Completed | Phase 1 | Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine | September 1996 | September 2000 |
| NCT01002755 | Completed | Phase 2 | Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | January 19, 2010 | January 31, 2018 |
| NCT02530515 | Completed | Phase 2 | Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia | December 18, 2015 | April 30, 2018 |
| NCT02948283 | Completed | Phase 1 | Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia | September 5, 2017 | December 1, 2017 |
| NCT02298816 | Withdrawn | B-Cell Hematologic Malignancy Vaccination Registry | August 2014 | December 2025 |
- HPO alt_id (Human Phenotype Ontology)
- HP:0012141
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0100827
- MeSH unique ID (MeSH (Medical Subject Headings))
- D008218